Novo Nordisk A/S Profit Margin

Novo Nordisk A/S posts a profit margin of 35.35% as of June 2026. That compares with 35.61% in the prior-year period — down 0.7% year over year. That is above the Healthcare sector average of 10.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Novo Nordisk A/S's profit margin was 35.61%. The latest reading is 35.35% — a 0.7% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 10.58% is typical. Novo Nordisk A/S's 35.35% is higher that level. That is roughly 234.1% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Novo Nordisk A/S's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 35.35% as of June 2026; use YoY and peer views to separate noise from signal.

Context for NOV.DE's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.58%), and (3) consistency with growth and profitability. This page covers the first two; Novo Nordisk A/S's other metric pages and overview cover the third.